Medicare Enrolled

Dr. Wilfred Kearse, M.D.

Urology Physician · La Mesa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8851 CENTER DR STE 501, La Mesa, CA 91942
6196972456
In practice since 2006 (19 years)
NPI: 1144232778 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kearse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kearse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kearse

Dr. Wilfred Kearse is an urology physician in La Mesa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kearse performed 3,223 Medicare services across 2,234 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kearse received a total of $4,166 from 49 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kearse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in CA $4,166 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,223
Medicare services
Top 26% in CA for urology physician
2,234
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~170 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
629 $70 $439
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
522 $3 $20
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
502 $9 $60
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
431 $101 $600
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
406 $52 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
160 $128 $773
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
111 $85 $531
Simple change of bladder tube 105 $80 $480
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
102 $202 $1,227
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
63 $2 $9
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
28 $41 $280
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
27 $321 $1,061
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
27 $6 $66
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
27 $28 $293
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $43 $280
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
23 $74 $440
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
20 $46 $310
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
13 $125 $730
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,166
Total received (2018-2024)
Avg $595/year across 7 years
Top 38% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,098 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$555
2023
$1,002
2022
$812
2021
$974
2020
$349
2019
$451
2018
$24

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$81
ABBVIE INC.
$63
ACCORD HEALTHCARE, INC.
$52
Antares Pharma, Inc.
$52
Endo Pharmaceuticals Inc.
$45
PFIZER INC.
$37
Blue Earth Diagnostics Limited
$33
Bayer Healthcare Pharmaceuticals Inc.
$30
Axonics, Inc.
$29
Merck Sharp & Dohme LLC
$28
Endo USA, Inc.
$24
Sumitomo Pharma America, Inc.
$21
IMMUNITYBIO, INC.
$21
Photocure Inc
$20
Dendreon Pharmaceuticals LLC
$19
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$340
Teleflex LLC
$308
Astellas Pharma US Inc
$273
NeoTract Inc.
$215
Myriad Genetic Laboratories, Inc.
$205
UroGen Pharma, Inc.
$188
Endo Pharmaceuticals Inc.
$180
Janssen Biotech, Inc.
$155
Axonics, Inc.
$146
UROGEN PHARMA, INC.
$142
Photocure Inc
$138
Merck Sharp & Dohme LLC
$130
Progenics Pharmaceuticals, Inc.
$119
180 Medical, Inc.
$113
Profound Medical Corp.
$112
ACCORD HEALTHCARE, INC.
$111
Bayer HealthCare Pharmaceuticals Inc.
$97
Myovant Sciences Inc.
$96
Antares Pharma, Inc.
$95
Sumitomo Pharma America, Inc.
$91
PFIZER INC.
$91
Hollister Incorporated
$91
ABBVIE INC.
$79
Coloplast Corp
$67
ConvaTec Inc.
$41
Supernus Pharmaceuticals, Inc.
$40
Mission Pharmacal Company
$39
Blue Earth Diagnostics Limited
$33
PALETTE LIFE SCIENCES, INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$30
UROVANT SCIENCES INC
$26
PROCEPT BioRobotics Corporation
$25
AbbVie Inc.
$25
Endo USA, Inc.
$24
Travere Therapeutics, Inc.
$22
Janssen Scientific Affairs, LLC
$21
Rochester Medical Corporation
$21
Alnylam Pharmaceuticals Inc.
$21
IMMUNITYBIO, INC.
$21
Olympus America Inc.
$20
AstraZeneca Pharmaceuticals LP
$20
Boston Scientific Corporation
$19
Dendreon Pharmaceuticals LLC
$19
Sagent Pharmaceuticals, Inc.
$16
ABC Home Medical Supply, Inc.
$15
Allergan Inc.
$15
C. R. Bard, Inc. & Subsidiaries
$13
Kowa Pharmaceuticals America, Inc.
$13
SRS Medical Systems, Inc.
$13
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · AVYCAZ · Axonics · Axonics r-SNM System · BOTOX · Balversa · CAMCEVI · CURE CATHETER · CYSVIEW · ERLEADA · GEMTESA · GENTLECATH · GENTLECATH GLIDE · GentleCath · Glydo · JELMYTO · KEYTRUDA · LUPRON DEPOT · Myrbetriq · Nubeqa · ORGOVYX · OXLUMO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Rezum Generator · SPEEDICATH · Seglentis · SpeediCath · TLANDO · TOVIAZ · Thiola · Tulsa-Pro · UROLIFT · Uribel · UroCuff · UroLift · UroLift System · VaPro · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in La Mesa?
Compare urology physicians in the La Mesa area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
131
Per 100K population
4.0
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kearse is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kearse experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kearse performed 629 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kearse receive payments from pharmaceutical companies?
Yes. Dr. Kearse received a total of $4,166 from 49 companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kearse's costs compare to other urology physicians in La Mesa?
Dr. Kearse's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kearse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →